- Home
- RXRX vs QTWO Comparison
RXRX vs QTWO Comparison
Compare RXRX & QTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RXRX | QTWO |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.9B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RXRX | QTWO |
|---|---|---|
| Price | $2.88 | $46.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $7.50 | ★ $86.25 |
| AVG Volume (30 Days) | ★ 11.5M | 846.2K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.79 | ★ 225.00 |
| EPS | N/A | ★ 0.80 |
| Revenue | $74,681,000.00 | ★ $193,978,000.00 |
| Revenue This Year | $12.11 | $12.48 |
| Revenue Next Year | $82.52 | $10.18 |
| P/E Ratio | ★ N/A | $56.88 |
| Revenue Growth | ★ 26.92 | N/A |
| 52 Week Low | $2.91 | $44.65 |
| 52 Week High | $7.18 | $95.10 |
Technical Indicators
Market Signals| Indicator | RXRX | QTWO |
|---|---|---|
| Relative Strength Index (RSI) | 28.02 | 35.49 |
| Support Level | N/A | $46.16 |
| Resistance Level | $5.03 | $52.96 |
| Average True Range (ATR) | 0.17 | 1.78 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 9.72 | 26.04 |
Price Performance
Historical ComparisonAbout RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About QTWO Q2 Holdings Inc.
Q2 Holdings Inc provides digital solutions to financial institutions, financial technology companies, and alternative finance companies, seeking to incorporate banking into their customer engagement and servicing strategies. The company helps its clients with supervisory, consumer protection, privacy, third-party risk management requirements, and cyber threats and fraud, among other applications, by offering a portfolio of digital solutions, which comprises its digital banking offerings, digital lending and relationship pricing solutions, risk and fraud solutions, as well as Q2 Innovation Studio and Helix. Q2 derives the majority of its revenue from subscription fees for the use of its hosted solutions.